The apolipoprotein E ε4 allele and decline in different cognitive systems during a 6-year period

Archives of Neurology

Volumn 59, Issue 7, 2002, Pages 1154-1160

  Wilson, Robert S ^a,b   Schneider, Julie A ^a,b   Barnes, Lisa L ^a,b   Beckett, Laurel A ^a,b   Aggarwal, Neelum T ^a,b   Cochran, Elizabeth J ^a,b   Berry Kravis, Elizabeth ^b   Bach, Julie ^a   Fox, Jacob H ^a,b   Evans, Denis A ^a,b   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; COGNITION; DEPTH PERCEPTION; DISEASE ASSOCIATION; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECALL; RELIGION; RISK FACTOR; SEMANTICS; WORKING MEMORY; GENETICS; LONGITUDINAL STUDY; MEMORY; PSYCHOLOGICAL ASPECT; RISK; UNITED STATES;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY; RISK; UNITED STATES;

EID: 0035983759     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.7.1154     Document Type: Article

References (54)

1. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
2. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease
3. Episodic memory changes are associated with the ApoE ε4 allele in nondemented older adults
4. Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E
5. Apolipoprotein E, memory and Alzheimer's disease
6. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease
7. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ε4 allele
8. Early effect of APOE-ε4 allele on cognitive results in a group of highly performing subjects: The EVA study
9. High apolipoprotein E ε4 frequency in age-related memory decline
10. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele
11. Apolipoprotein e4 allele and cognitive decline in elderly men
12. The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons
13. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study
14. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample
15. Apolipoprotein E and cognitive change in an elderly population
16. Association between apolipoprotein E ε4 and the rate of cognitive decline in community dwelling elderly individuals with and without dementia
17. The APOE ε4 allele is associated with decline on delayed recall performance in community-dwelling older adults
18. Cognitive function and apolipoprotein E in very old adults: Findings from the Nun Study
19. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia
20. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women
21. Metric properties of nurses ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale
22. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment
23. Entorhinal cortex β-amyloid load in individuals with mild cognitive impairment
24. Individual differences in rates of change in cognitive abilities of older persons
25. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS/ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
26. Mini-Mental State: A practical method for grading the mental state of patients for the clinician
27. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part V: A normative study of the neuropsychological battery
28. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease
29. Predicting premorbid IQ: A revision of the National Adult Reading Test
30. Development and validation of a model for estimating premorbid verbal intelligence in the elderly
31. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability
32. A functional account of age differences in memory
33. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal
34. Regression models and life tables
35. Random-effects models for longitudinal data
36. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age
37. Apolipoprotein E ε4 and incidence of Alzheimer's disease in a community population of older persons
38. Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia
39. Apolipoprotein E ε4 association with dementia in a population-based study: The Framingham Study
40. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam Study
41. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein
42. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
43. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease
44. Apolipoprotein E polymorphism and atherosclerosis
45. Apolipoprotein E polymorphisms affect atherosclerosis in young males: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group
46. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks